HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert S Reneman Selected Research

perflexane (perfluorohexane)

1/2015Echogenic perfluorohexane-loaded macrophages adhere in vivo to activated vascular endothelium in mice, an explorative study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert S Reneman Research Topics

Disease

4Thrombosis (Thrombus)
04/2007 - 04/2002
3Thromboembolism
04/2007 - 04/2002
2Closed Head Injuries
07/2005 - 09/2002
2Embolism (Embolus)
03/2003 - 11/2002
1Atherosclerosis
01/2015
1Hypertension (High Blood Pressure)
08/2014
1Pathologic Constriction (Stenosis)
01/2010
1Hemorrhage
04/2007
1Diabetes Mellitus
03/2006
1Wounds and Injuries (Trauma)
07/2005
1Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
08/2004
1Stroke (Strokes)
04/2003
1Hypercholesterolemia
04/2002

Drug/Important Bio-Agent (IBA)

3Adenosine Diphosphate (ADP)IBA
04/2007 - 11/2002
2Purinergic P2 Receptors (ADP Receptor)IBA
04/2007 - 03/2003
1perflexane (perfluorohexane)FDA Link
01/2015
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
08/2014
1Indicators and Reagents (Reagents)IBA
01/2010
1Hemostatics (Antihemorrhagics)IBA
04/2007
1ThrombinFDA Link
04/2007
1Glucose (Dextrose)FDA LinkGeneric
03/2006
1Oxygen (Dioxygen)IBA
07/2005
1BarbituratesIBA
07/2005
1Pentobarbital (Nembutal)FDA Link
07/2005
1ElastinIBA
08/2004
1Proteoglycans (Proteoglycan)IBA
08/2004
1CalciumIBA
08/2004
1Purinergic P2Y Receptor AntagonistsIBA
03/2003
1CollagenIBA
11/2002
1salicylhydroxamic acid (SHAM)IBA
09/2002
1CholesterolIBA
04/2002
1Arginine (L-Arginine)FDA Link
04/2002

Therapy/Procedure

2Punctures
04/2007 - 11/2002
1Catheters
04/2003
1Secondary Prevention
03/2003